Page 498 - ஒன்றுபட்டது மாநிலங்களில் காங்கிரஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(1) RALEIGH, NC / ACCESSWIRE / March 9, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today that chief medical officer Patrick Griffin, M.D., FACP, will participate in an invited presentation at an upcoming virtual workshop entitled Accelerating Progress in Celiac Disease. The workshop is a National Institutes of Health workshop co-sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), to be held on March 18-19, 2021. Dr. Griffin commented, I am grateful for the opportunity to raise awareness of larazotide s immense potential for patients living with celiac disease, especially those who continue to experience life-altering symptoms while following a gluten-free diet. In the absence of an approved pharmaceutical treatment for celiac disease, these patients are long overdue for a source of some relie

United statesCorey davisAmy jobePatrick griffinLifesci advisorsNational institute of allergyNational institutes of healthMeters biopharma incLifesci communicationsNational institutes of diabetesUnited states congressAccelerating progressNational institutesNational instituteInfectious diseasesKidney diseases